Invention Grant
- Patent Title: Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
-
Application No.: US16772428Application Date: 2018-12-14
-
Publication No.: US11292799B2Publication Date: 2022-04-05
- Inventor: Mark Andrews , Daniel Rodriguez Greve , Jens Larsen
- Applicant: UNION therapeutics A/S
- Applicant Address: DK Hellerup
- Assignee: UNION therapeutics A/S
- Current Assignee: UNION therapeutics A/S
- Current Assignee Address: DK Hellerup
- Agency: DLA Piper LLP (US)
- Priority: EP17207659 20171215
- International Application: PCT/EP2018/084974 WO 20181214
- International Announcement: WO2019/115774 WO 20190620
- Main IPC: C07D495/04
- IPC: C07D495/04
Abstract:
The present invention relates to novel substituted azetidine dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
Public/Granted literature
- US20210070769A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Public/Granted day:2021-03-11
Information query
